ANXA1 and gastroesophageal junction adenocarcinoma: Wang et al. revealed that high expression of ANXA1 is prevalent in esophageal and esophagogastric junction adenocarcinomas, which is associated with more advanced pathologic T stage and the presence of distant metastases and is an independent prognostic factor for patient survival [35].